Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'TP53' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 264 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Marsh, A; Spurdle, AB; Turner, BC; Fereday, S; Thorne, H; Pupo, GM; Mann, GJ; Hopper, JL; Sambrook, JF; Chenevix-Trench, G
      The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia

      BREAST CANCER RESEARCH
    2. Millon, R; Muller, D; Schultz, I; Salvi, R; Ghnassia, JP; Frebourg, T; Wasylyk, B; Abecassis, J
      Loss of MDM2 expression in human head and neck squamous cell carcinomas and clinical significance

      ORAL ONCOLOGY
    3. Horiguchi, H; Sano, T; Hirose, T
      TP53 deleted cells in de novo glioblastomas using fluorescence in situ hybridization

      PATHOLOGY INTERNATIONAL
    4. Gump, J; McGavran, L; Wei, Q; Hunger, SP
      Analysis of TP53 mutations in relapsed childhood acute lymphoblastic leukemia

      JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
    5. Rogozin, IB; Kondrashov, FA; Glazko, GV
      Use of mutation spectra analysis software

      HUMAN MUTATION
    6. Nichols, KE; Malkin, D; Garber, JE; Fraumeni, JF; Li, FP
      Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers

      CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
    7. Olivier, M; Hainaut, P
      TP53 mutation patterns in breast cancers: searching for clues of environmental carcinogenesis

      SEMINARS IN CANCER BIOLOGY
    8. Graf, J; Merk, B; Maurer, U; Muller, E; Bergmann, L
      Identification of novel polymorphisms in intron 7 of the human p53 gene inacute myeloid leukemia and healthy donors

      LEUKEMIA & LYMPHOMA
    9. Ngan, HYS; Cheung, ANY; Liu, SS; Cheng, DKL; Ng, TY; Wong, LC
      Abnormal expression of pan-ras, c-myc and tp53 in squamous cell carcinoma of cervix: correlation with HPV and prognosis

      ONCOLOGY REPORTS
    10. Balassiano, IT; De Paulo, SA; Silva, NH; Cabral, MC; Carvalho, MDD
      Metastatic potential of MDA435 and Hep2 cell lines in chorioallantoic membrane (CAM) model

      ONCOLOGY REPORTS
    11. Yoon, KS; Lee, MC; Kang, SS; Kim, JH; Jung, S; Kim, YJ; Lee, JH; Ahn, KY; Lee, JS; Cheon, JY
      p53 mutation and epidermal growth factor receptor overexpression in glioblastoma

      JOURNAL OF KOREAN MEDICAL SCIENCE
    12. Bjorheim, J; Gaudernack, G; Ekstrom, PO
      Mutation analysis of TP53 exons 5-8 by automated constant denaturant capillary electrophoresis

      TUMOR BIOLOGY
    13. Hosokawa, Y; Papanikolaou, A; Cardiff, RD; Yoshimoto, K; Bernstein, M; Wang, TC; Schmidt, EV; Arnold, A
      In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53

      TRANSGENIC RESEARCH
    14. Supino, R; Perego, P; Gatti, L; Caserini, C; Leonetti, C; Colantuono, M; Zuco, V; Carenini, N; Zupi, G; Zunino, F
      A role for c-myc in DNA damage-induced apoptosis in a human TP53-mutant small-cell lung cancer cell line

      EUROPEAN JOURNAL OF CANCER
    15. Olsson, H
      A hypothesis about tumour development and the clinical features of hereditary breast cancers

      EUROPEAN JOURNAL OF CANCER
    16. Lefevre, SH; Vogt, N; Dutrillaux, AM; Chauveinc, K; Stoppa-Lyonnet, D; Doz, F; Desjardins, L; Dutrillaux, B; Chevillard, S; Malfoy, B
      Genome instability in secondary solid tumors developing after radiotherapyof bilateral retinoblastoma

      ONCOGENE
    17. Birch, JM; Alston, RD; McNally, RJQ; Evans, DGR; Kelsey, AM; Harris, M; Eden, OB; Varley, JM
      Relative frequency and morphology of cancers in carriers of germline TP53 mutations

      ONCOGENE
    18. Varley, JM; Attwooll, C; White, G; McGown, G; Thorncroft, M; Kelsey, AM; Greaves, M; Boyle, J; Birch, JM
      Characterization of germline TP53 splicing mutations and their genetic andfunctional analysis

      ONCOGENE
    19. Christiansen, DH; Andersen, MK; Pedersen-Bjergaard, J
      Mutations with loss of heterozygosity of p53 are common in therapy-relatedmyelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis

      JOURNAL OF CLINICAL ONCOLOGY
    20. Forslund, A; Lonnroth, C; Andersson, M; Brevinge, H; Lundholm, K
      Mutations and allelic loss of p53 in primary tumor DNA from potentially cured patients with colorectal carcinoma

      JOURNAL OF CLINICAL ONCOLOGY
    21. Kimura, K; Shinmura, K; Hasegawa, T; Beppu, Y; Yokoyama, R; Yokota, J
      Germline p53 mutation in a patient with multiple primary cancers

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    22. Alsner, J; Hoyer, M; Sorensen, SB; Overgaard, J
      Interaction between potential doubling time and TP53 mutation: Predicting radiotherapy outcome in squamous cell carcinoma of the head and neck

      INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
    23. Soues, S; Wiltshire, M; Smith, PJ
      Differential sensitivity to etoposide (VP-16)-induced S phase delay in a panel of small-cell lung carcinoma cell lines with G1/S phase checkpoint dysfunction

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    24. Guimaraes, DP; Lu, SH; Snijders, P; Wilmotte, R; Herrero, R; Lenoir, G; Montesano, R; Meijer, CJLM; Walboomers, J; Hainaut, P
      Absence of association between HPV DNA, TP53 codon 72 polymorphism, and risk of oesophageal cancer in a high-risk area of China

      CANCER LETTERS
    25. Lehnert, NM; Gary, RK; Marrone, BL; Lehnert, BE
      Inhibition of normal human lung fibroblast growth by beryllium

      TOXICOLOGY
    26. Bar, JK; Harlozinska, A; Sedlaczek, P; Kasiak, J; Markowska, J
      Relations between the expression of p53, c-erbB-2, Ki-67 and HPV infectionin cervical carcinomas and cervical dysplasias

      ANTICANCER RESEARCH
    27. Alsner, J; Sorensen, SB; Overgaard, J
      TP53 mutation is related to poor prognosis after radiotherapy, but not surgery, in squamous cell carcinoma of the head and neck

      RADIOTHERAPY AND ONCOLOGY
    28. Powell, BL; Bydder, S; Grieu, F; Gnanasampanthan, G; Elsaleh, H; Seshadri, R; Berns, EMJJ; Iacopetta, B
      Prognostic value of TP53 gene mutation in adjuvant treated breast cancer patients

      BREAST CANCER RESEARCH AND TREATMENT
    29. Querzoli, P; Albonico, G; de Iasio, MG; Ferretti, S; Rinaldi, R; Cariello, A; Pedriali, M; Matteuzzi, M; Maestri, I; Nenci, I
      Biophenotypes and survival of BRCA1 and TP53 deleted breast cancer in young women

      BREAST CANCER RESEARCH AND TREATMENT
    30. Ho, GH; Calvano, JE; Bisogna, M; Abouezzi, Z; Borgen, PI; Cordon-Cardo, C; Van Zee, KJ
      Genetic alterations of the p14(ARF)-hdm2-p53 regulatory pathway in breast carcinoma

      BREAST CANCER RESEARCH AND TREATMENT
    31. Portwine, C; Chilton-MacNeill, S; Brown, C; Sexsmith, E; McLaughlin, J; Malkin, D
      Absence of germline and somatic p53 alterations in children with sporadic brain tumors

      JOURNAL OF NEURO-ONCOLOGY
    32. Gross, E; Kiechle, M; Arnold, N
      Mutation analysis of p53 in ovarian rumors by DHPLC

      JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS
    33. Pinheiro, NA; Villa, LL
      Low frequency of p53 mutations in cervical carcinomas among Brazilian women

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    34. Reedy, MB; Hang, T; Gallion, H; Arnold, S; Smith, SA
      Antisense inhibition of BRCA1 expression and molecular analysis of hereditary tumors indicate that functional inactivation of the p53 DNA damage response pathway is required for BRCA-associated tumorigenesis

      GYNECOLOGIC ONCOLOGY
    35. Ribeiro, RC; Sandrini, F; Figueiredo, B; Zambetti, GP; Michalkiewicz, E; Lafferty, AR; DeLacerda, L; Rabin, M; Cadwell, C; Sampaio, G; Cat, I; Stratakis, CA; Sandrini, R
      A inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    36. Gnanasampanthan, G; Elsaleh, H; McCaul, K; Iacopetta, B
      Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer

      JOURNAL OF PATHOLOGY
    37. Seitz, S; Poppe, K; Fischer, J; Nothnagel, A; Estevez-Schwarz, L; Haensch, W; Schlag, PM; Scherneck, S
      Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters

      JOURNAL OF PATHOLOGY
    38. Hayashi, Y; Iwato, M; Hasegawa, M; Tachibana, O; von Deimling, A; Yamashita, J
      Malignant transformation of a gangliocytoma/ganglioglioma into a glioblastoma multiforme: a molecular genetic analysis - Case report

      JOURNAL OF NEUROSURGERY
    39. Watanabe, T; Yokoo, H; Yokoo, M; Yonekawa, Y; Kleihues, P; Ohgaki, H
      Concurrent inactivation of RB1 and TP53 pathways in anaplastic oligodendrogliomas

      JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    40. Joachim, T; Ram, Z; Rappaport, ZH; Simon, M; Schramm, J; Wiestler, OD; von Deimling, A
      Comparative analysis of the NF2, TP53, PTEN, KRAS, NRAS and HRAS genes in sporadic and radiation-induced human meningiomas

      INTERNATIONAL JOURNAL OF CANCER
    41. Bleeker, WA; Hayes, VM; Karrenbeld, A; Hofstra, RMW; Verlind, E; Hermans, J; Poppema, S; Buys, CHCM; Plukker, JTM
      Prognostic significance of K-ras and TP53 mutations in the role of adjuvant chemotherapy on survival in patients with Dukes C colon cancer

      DISEASES OF THE COLON & RECTUM
    42. Keshelava, N; Zuo, JJ; Chen, P; Waidyaratne, SN; Luna, MC; Gomer, CJ; Triche, TJ; Reynolds, CP
      Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines'

      CANCER RESEARCH
    43. Kita-Sasai, Y; Horiike, S; Misawa, S; Kaneko, H; Kobayashi, M; Nakao, M; Nakagawa, H; Fujii, H; Taniwaki, M
      International prognostic scoring system and TP53 mutations are independentprognostic indicators for patients with myelodysplastic syndrome

      BRITISH JOURNAL OF HAEMATOLOGY
    44. Schuyer, M; van der Burg, MEL; Henzen-Logmans, SC; Fieret, JH; Klijn, JGM; Look, MP; Foekens, JA; Stoter, G; Berns, EMJJ
      Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2

      BRITISH JOURNAL OF CANCER
    45. Taniere, P; Martel-Planche, G; Saurin, JC; Lombard-Bohas, C; Berger, F; Scoazec, JY; Hainaut, P
      TP53 mutations, amplification of P63 and expression of cell cycle proteinsin squamous cell carcinoma of the oesophagus from a low incidence area in Western Europe

      BRITISH JOURNAL OF CANCER
    46. Berggren, P; Steineck, G; Adolfsson, J; Hansson, J; Jansson, O; Larsson, P; Sandstedt, B; Wijkstrom, H; Hemminki, K
      p53 mutations in urinary bladder cancer

      BRITISH JOURNAL OF CANCER
    47. Rapakko, K; Allinen, M; Syrjakoski, K; Vahteristo, P; Huusko, P; Vahakangas, K; Eerola, H; Kainu, T; Kallioniemi, OP; Nevanlinna, H; Winqvist, R
      Germline TP53 alterations in Finnish breast cancer families are rare and occur at conserved mutation-prone sites

      BRITISH JOURNAL OF CANCER
    48. Rickert, CH; Strater, R; Kaatsch, P; Wassmann, H; Jurgens, H; Dockhorn-Dworniczak, B; Paulus, W
      Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases

      AMERICAN JOURNAL OF PATHOLOGY
    49. Kim, JW; Roh, JW; Park, NH; Song, YS; Kang, SB; Lee, HP
      Polymorphism of TP53 codon 72 and the risk of cervical cancer among Koreanwomen

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    50. Reis, RM; Hara, A; Kleihues, P; Ohgaki, H
      Genetic evidence of the neoplastic nature of gemistocytes in astrocytomas

      ACTA NEUROPATHOLOGICA
    51. Tonin, PN
      Genes implicated in hereditary breast cancer syndromes

      SEMINARS IN SURGICAL ONCOLOGY
    52. Gudlaugsdottir, S; Sigurdardottir, V; Snorradottir, M; Jonasson, JG; Ogmundsdottir, H; Eyfjord, JE
      P53 mutations analysis in benign and malignant breast lesions: Using needle rinses from fine-needle aspirations

      DIAGNOSTIC CYTOPATHOLOGY
    53. Strauss, BS
      Role in tumorigenesis of silent mutations in the TP53 gene

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    54. Trejo-Becerril, C; Sarmiento, RG; Abad, MM; Ichaso, N; Delgado, R; Cruz, JJ; Duenas-Gonzalez, A
      Immunohistochemical expression of p53 in breast carcinoma is associated with the intron 1 BglII polymorphism of the p53 gene

      MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    55. Schmitz-Drager, BJ; Goebell, PJ; Heydthausen, M
      p53 immunohistochemistry in bladder cancer - Combined analysis: a way to go?

      UROLOGIC ONCOLOGY
    56. Skaug, V; Ryberg, D; Kure, EH; Arab, MO; Stangeland, L; Myking, AO; Haugen, A
      p53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients

      CLINICAL CANCER RESEARCH
    57. Powell, B; Soong, R; Iacopetta, B; Seshadri, R; Smith, DR
      Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer

      CLINICAL CANCER RESEARCH
    58. Dunn, JR; Garde, J; Dolan, K; Gosney, JR; Oates, BC; Watson, AJM; Fielding, P; Field, JK
      The evolution of loss of heterozygosity on chromosome 17 during the progression to Barrett's adenocarcinoma involves a unique combination of target sites in individual specimens

      CLINICAL CANCER RESEARCH
    59. Grzybowska, E; Zientek, H; Jasinska, A; Rusin, M; Kozlowski, P; Sobczak, K; Sikorska, A; Kwiatkowska, E; Gorniak , L; Kalinowska, E; Utracka-Hutka, B; Wloch, J; Chmielik, E; Krzyzosiak, WJ
      High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer

      HUMAN MUTATION
    60. Logullo, AF; de Moura, RP; Nonogaki, S; Kowalski, LP; Nagai, MA; Simpson, AJG
      A proposal for the integration of immunohistochemical staining and DNA-based techniques for the determination of TP53 mutations in human carcinomas

      DIAGNOSTIC MOLECULAR PATHOLOGY
    61. Della Torre, G; Pasquini, G; Pilotti, S; Alasio, L; Civelli, E; Cozzi, G; Milella, M; Salvetti, M; Pierotti, MA; Severini, A
      TP53 mutations and mdm2 protein overexpression in cholangiocarcinomas

      DIAGNOSTIC MOLECULAR PATHOLOGY
    62. Britten, RA; Perdue, S; Eshpeter, A; Merriam, D
      Raf-1 kinase activity predicts for paclitaxel resistance in TP53(mut), butnot TP53(wt) human ovarian cancer cells

      ONCOLOGY REPORTS
    63. Ozkan, S; Fetil, E; Aydogan, T; Atabey, N; Erkizan, V; Pabuccuoglu, U; Gunes, AT
      Lack of TP53 mutations in a case of porokeratosis palmaris, plantaris et disseminata

      DERMATOLOGY
    64. Sung, T; Miller, DC; Hayes, RL; Alonso, M; Yee, H; Newcomb, EW
      Preferential inactivation of the p53 tumor suppressor pathway and lack of EGFR amplification distinguish de novo high grade pediatric astrocytomas from de novo adult astrocytomas

      BRAIN PATHOLOGY
    65. Westhof, G; Bader, W; Greiner-Mai, E; Hatzmann, W
      Comparison of cytosolic p53 protein levels in the female genital tract andbreast, and their tumors

      TUMOR BIOLOGY
    66. Cesinaro, AM; Migaldi, M; Ferrari, G; Castagnetti, G; Dotti, A; De Gaetani, C; Ferrari, P; Trentini, GP
      Expression of p53 and bcl-2 in clinically localized prostate cancer beforeand after neo-adjuvant hormonal therapy

      ONCOLOGY RESEARCH
    67. Bouzourene, H; Gervaz, P; Cerottini, JP; Benhattar, J; Chaubert, P; Saraga, E; Pampallona, S; Bosman, FT; Givel, JC
      p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer

      EUROPEAN JOURNAL OF CANCER
    68. Soong, R; Powell, B; Elsaleh, H; Gnanasampanthan, G; Smith, DR; Goh, HS; Joseph, D; Iacopetta, B
      Prognostic significance of TP53 gene mutation in 995 cases of colorectal carcinoma: influence of tumour site, stage, adjuvant chemotherapy and type of mutation

      EUROPEAN JOURNAL OF CANCER
    69. Takahashi, M; Kigawa, J; Minagawa, Y; Itamochi, H; Shimada, M; Kamazawa, S; Sato, S; Akeshima, R; Terakawa, N
      Sensitivity to paclitaxel is not related to p53-dependent apoptosis in ovarian cancer cells

      EUROPEAN JOURNAL OF CANCER
    70. Shimada, M; Kigawa, J; Kanamori, Y; Itamochi, H; Takahashi, M; Kamazawa, S; Sato, S; Terakawa, N
      Mechanism of the combination effect of wild-type TP53 gene transfection and cisplatin treatment for ovarian cancer xenografts

      EUROPEAN JOURNAL OF CANCER
    71. Heimann, R; Hellman, S
      Individual characterisation of the metastatic capacity of human breast carcinoma

      EUROPEAN JOURNAL OF CANCER
    72. Verselis, SJ; Rheinwald, JG; Fraumeni, JF; Li, FP
      Novel p53 splice site mutations in three families with Li-Fraumeni syndrome

      ONCOGENE
    73. Horie, S; Endo, K; Kawasaki, H; Terada, T
      Overexpression of MDM2 protein in intrahepatic cholangiocarcinoma: relationship with p53 overexpression, Ki-67 labeling, and clinicopathological features

      VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    74. Nutting, C; Camplejohn, RS; Gilchrist, R; Tait, D; Blake, P; Knee, G; Yao, WQ; Ross, G; Fisher, C; Eeles, R
      A patient with 17 primary tumours and a germ line mutation in TP53: Tumourinduction by adjuvant therapy?

      CLINICAL ONCOLOGY
    75. Bossi, G; Scardigli, R; Musiani, P; Martinelli, R; Gentileschi, MP; Soddu, S; Sacchi, A
      Development of a murine orthotopic model of leukemia: Evaluation of TP53 gene therapy efficacy

      CANCER GENE THERAPY
    76. Kihara, C; Seki, T; Furukawa, Y; Yamana, H; Kimura, Y; van Schaardenburgh, P; Hirata, K; Nakamura, Y
      Mutations in zinc-binding domains of p53 as a prognostic marker of esophageal-cancer patients

      JAPANESE JOURNAL OF CANCER RESEARCH
    77. Cousin, P; Billotte, J; Chaubert, P; Shaw, P
      Physical map of 17p13 and the Genes Adjacent to p53

      GENOMICS
    78. Gerdes, B; Bartsch, DK; Ramaswamy, A; Kersting, M; Wild, A; Schuermann, M; Frey, M; Rothmund, M
      Multiple primary tumors as an indicator for p16(INK4a) germline mutations in pancreatic cancer patients?

      PANCREAS
    79. Toki, T; Nakayama, K
      Proliferative activity and genetic alterations in TP53 in endometriosis

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    80. Thomas, EJ; Campbell, IG
      Molecular genetic defects in endometriosis

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    81. Kubota, N; Okada, S; Inada, T; Ohnishi, K; Ohnishi, T
      Wortmannin sensitizes human glioblastoma cell lines carrying mutant and wild type TP53 gene to radiation

      CANCER LETTERS
    82. Katsama, A; Sourvinos, G; Zachos, G; Spandidos, DA
      Allelic loss at the BRCA1, BRCA2 and TP53 loci in human sporadic breast carcinoma

      CANCER LETTERS
    83. Chen, WC; Tsai, FJ; Wu, JY; Wu, HC; Lu, HF; Li, CW
      Distributions of p53 codon 72 polymorphism in bladder cancer - proline form is prominent in invasive tumor

      UROLOGICAL RESEARCH
    84. Werness, BA; Ramus, SJ; Whittemore, AS; Garlinghouse-Jones, K; Oakley-Girvan, I; DiCioccio, RA; Tsukada, Y; Ponder, BAJ; Piver, MS
      Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
    85. Hellstrom, AC; Blegen, H; Malec, M; Silfversward, C; Lystad, S; Borresen-Dale, A; Auer, G
      Recurrent fallopian tube carcinoma: TP53 mutation and clinical course

      INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
    86. Berggren, P; Hemminki, K; Steineck, G
      p53 intron 7 polymorphisms in urinary bladder cancer patients and controls

      MUTAGENESIS
    87. Gottschlich, S; Maune, S; Preugschat, J; Hoffmann, M; Werner, JA; Maass, JD; Gorogh, T; Heidorn, K; Rudert, H
      p53 analysis of laryngeal cancer in exon 4 to 9

      ANTICANCER RESEARCH
    88. Michie, J; Janssens, D; Cilliers, J; Smit, BJ; Bohm, L
      Assessment of electroporation by flow cytometry

      CYTOMETRY
    89. Kraus, JA; Glesmann, N; Beck, M; Krex, D; Klockgether, T; Schackert, G; Schlegel, U
      Molecular analysis of the PTEN, TP53 and CDKN2A tumor suppressor genes in long-term survivors of glioblastoma multiforme

      JOURNAL OF NEURO-ONCOLOGY
    90. Tachibana, I; Smith, JS; Sato, K; Hosek, SM; Kimmel, DW; Jenkins, RB
      Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma

      AMERICAN JOURNAL OF MEDICAL GENETICS
    91. Burbano, RR; Medeiros, AC; Mello, AA; Lemos, JA; Bahia, MO; Casartelli, C
      Investigation of single-strand conformational polymorphism of the TP53 gene in women with a family history of breast cancer

      BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
    92. Webley, KM; Shorthouse, AJ; Royds, JA
      Effect of mutation and conformation on the function of p53 in colorectal cancer

      JOURNAL OF PATHOLOGY
    93. Park, CC; Hartmann, C; Folkerth, R; Loeffler, JS; Wen, PY; Fine, HA; Black, PM; Shafman, T; Louis, DN
      Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones

      JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
    94. Kennedy, AS; Harrison, GH; Mansfield, CM; Zhou, XJ; Xu, JF; Balcer-Kubiczek, EK
      Survival of colorectal cancer cell lines treated with paclitaxel, radiation, and 5-FU: Effect of TP53 or hMLH1 deficiency

      INTERNATIONAL JOURNAL OF CANCER
    95. Blaszyk, H; Hartmann, A; Cunningham, JM; Schaid, D; Wold, LE; Kovach, JS; Sommer, SS
      A prospective trial of midwest breast cancer patients: A p53 gene mutationis the most important predictor of adverse outcome

      INTERNATIONAL JOURNAL OF CANCER
    96. Taubert, H; Thamm, B; Meye, A; Bartel, F; Rost, AK; Heidenreich, D; John, V; Brandt, J; Bache, M; Wurl, P; Schmidt, H; Riemann, D
      The p53 status in juvenile chronic arthritis and rheumatoid arthritis

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    97. Lehman, TA; Haffty, BG; Carbone, CJ; Bishop, LR; Gumbs, AA; Krishnan, S; Shields, PG; Modali, R; Turner, BC
      Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer

      CANCER RESEARCH
    98. Cuny, M; Kramar, A; Courjal, F; Johannsdottir, V; Iacopetta, B; Fontaine, H; Grenier, J; Culine, S; Theillet, C
      Relating genotype and phenotype in breast cancer: An analysis of the prognostic significance of amplification at eight different genes or loci and ofp53 mutations

      CANCER RESEARCH
    99. Shahin, MS; Hughes, JH; Sood, AK; Buller, RE
      The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma

      CANCER
    100. Burt, EC; James, LA; Greaves, MJ; Birch, JM; Boyle, JM; Varley, JM
      Genomic alterations associated with loss of heterozygosity for TP53 in Li -Fraumeni syndrome fibroblasts

      BRITISH JOURNAL OF CANCER


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 21:27:34